U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments
U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments
RELEASE DATE
02-May-2011
02-May-2011
REGION
North America
North America
Deliverable Type
Market Research
Market Research
Research Code: N96E-01-00-00-00
SKU: HC02194-NA-MR_07863
£3,955.55
Special Price £2,966.66 save 25 %
In stock
SKU
HC02194-NA-MR_07863
Description
This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service are products currently in the market, products in development, and patient forecasts. Market challenges, drivers, and restraints are identified and assessed. Strategic recommendations are presented to overcome listed industry challenges. This research service does not include market revenue forecasts for DMARDs. This research service highlights product forecasts for biologic products as well as small molecules near launch.
Table of Contents
Analysis of the U.S. Rheumatoid Arthritis Market
- Research Service
This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service are products currently in the market, products in development, and patient forecasts. Market challenges, drivers, and restraints are identified and assessed. Strategic recommendations are presented to overcome listed industry challenges. This research service does not include market revenue forecasts for DMARDs. This research service highlights product forecasts for biologic products as well as small molecules near launch.
Deliverable Type | Market Research |
---|---|
No Index | Yes |
Podcast | No |
Author | Jennifer Lazar |
Industries | Healthcare |
WIP Number | N96E-01-00-00-00 |
Is Prebook | No |